View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
Practitioners should use care when prescribing simvastatin (Simcor, Zocor, Vytorin) to patients who also take amiodarone (Cordarone, Pacerone), according to a recent FDA alert. The combination may trigger rhabdomyolysis, a rare complication that can cause kidney failure and death. The risk is greatest with simvastatin doses above 20 mg/day. The FDA urges prescribers to consider using another statin for patients taking amiodarone, particularly if they require simvastatin doses above 20 mg/day.
All statin cholesterol-lowering drugs carry a risk of potentially fatal muscle injury, especially in older adults. Teach patients taking statins about the risks and tell them to call their health care provider immediately if they develop symptoms of muscle injury, such as muscle cramps, pain, tenderness, stiffness, or spasm.
For more information, visit the FDA's Web site at http://www.fda.gov.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top